Search for an unrelated HLA-compatible stem cell donor

Current Opinion in Hematology

Volumn 6, Issue 6, 1999, Pages 365-370

  Roosnek, Eddy ^a,b   Tiercy, Jean Marie ^a  

^a Transplant Immunol U   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ALLELE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE LINKAGE DISEQUILIBRIUM; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TISSUE TYPING;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032693092     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199911000-00002     Document Type: Article

References (46)

1. 1 Mach B: Genetics of histocompatibility. Curr Opin Hematol 1994, 1:4-11.
2. 2 Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, et al.: Nomenclature for factors of the HLA system, 1998. Tissue Antigens 1999, 53:407-446.
3. 3 Speiser D, Tiercy J-M, Rufer N, Chapuis B, Morell A, Kern M, et al.: Relation between the resolution of HLA-typing and the chance of finding an unrelated bone marrow donor. Bone Marrow Transplant 1994, 13:805-809.
4. 4 Oudshoorn M, Cornelissen JJ, Fibbe WE, de Graeff-Meeder ER, Lie JL, Schreuder GM, et al.: Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients. Bone Marrow Transplant 1997, 20:1011-1017.
5. 5 Madrigal JA, Scott I, Arguello R, Szydlo R, Little AM, Goldman JM: Factors influencing the outcome of bone marrow transplants using unrelated donors. Immunol Rev 1997, 157:153-166.
6. 6 Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG, et al.: The significance of HLA-DR81 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995, 86:1606-1613.
7. 7 Speiser DE, Tiercy J-M, Rufer N, Grundschober C, Gratwohl A, Chapuis B, et al: High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation. Blood 1996, 87:4455-4462.
8. 8 Sasazuki T, Juji T, Morishima Y, Kinukawa N, Kashiwabara H, Inoko H, et al.: Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program. N Engl J Med 1998, 339:1177-1185. This is an analysis of the effect of HLA class I and class II mismatches (high-resolution typing) on the outcome of 440 transplantations with unrelated stern cell donors. The 1-year survival rate of fully matched HLA-AI-BI-CI-DRB1 patients was 65%. Multivariate analysis showed that only HLA-A mismatches correlated with lower survival. In contrast, neither HLA-BI-C nor HLA-DRBI-DQ mismatches appeared to influence survival, although the univariate analysis showed an effect of HLA-B.
9. 9 Petersdorf EW, Gooley TA, Anasetti C, Martin PJ, Smith AG, Mickelson EM, et al.: Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998, 92:3515-3520. This is a multivariate analysis of the effect of HLA class I and class II mismatches (high-resolution typing) in a group of 300 chronic myeloid leukemia patients transplanted with stem cells from an unrelated donor. The article shows that mismatching for a single class I or class II allele had little effect on survival. Only a combination of two mismatches increased mortality. Overall 5-year survival of fully matched pairs was at 56%.
10. 10 Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, et al.: Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. N Engl J Med 1998, 338:962-968. These authors present the clinical outcome of 196 chronic myeloid leukemia patients in the chronic phase who received unrelated stem cell transplants between 1985 and 1994. Kaplan-Meier estimate of 5-year survival was 74% for patients under 50 years of age who underwent transplantation during the first year after diagnosis with marrow from an ABDR-matched donor. Donor/recipient pairs were HLA-AI-B typed by serology and DNA-typed for HLA-DRB1. The article shows that HLA-DRB1 mismatches increased mortality, whereas HLA-AI -B mismatches did not. However, these results should be interpreted with caution because HLA-DRB1-mismatched pairs are more often mismatched for class I alleles not detected by serology than HLA-DRB1-matched combinations.
11. 11 McGlave P, Bartsch G, Anasetti C, Ash R, Beatty P, Gajewski J, et al.: Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the national marrow donor program. Blood 1993, 81:543-550.
12. 12 Kernan NA, Bartsch G, Ash R, Beatty P, Champlin R, Filipovich A, et al.: Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 1993, 328:593-602.
13. 13 Little AM, Marsh SG, Madrigal JA: Current methodologies of human leukocyte antigen typing utilized for bone marrow donor selection. Curr Opin Hematol 1998, 5:419-428.
14. 14 Dausset J: Leuko-agglutinins IV: Leuko-agglutinins and blood transfusion. Vox Sanguinis 1954, 4:190-198.
15. 15 Mytilineos J, Scherer S, Dunckley H, Trejaut J, Chapman J, Fischer G, et al.: DNA HLA-DR typing results of 4000 kidney transplants. Transplantation 1993, 55:778-781.
16. 16 Rufer N, Tiercy J-M, Breur-Vriesendorp B, Gauchat-Feiss D, Shi X, Slavcev A, et al.: Histoincompatibilities in ABDR-matched unrelated donor recipient combinations. Bone Marrow Transplant 1995, 16:641-646.
17. 17 Prasad VK, Kernan NA, Heller G, O'Reilly RJ, Yang SY: DNA typing for HLA-A and HLA-B identifies disparities between patients and unrelated donors matched by HLA-A and HLA-B serology and HLA-DRB1. Blood 1999, 93:399-409. These authors describe large-scale HLA-AI-B sequence-specific oligonucleotide typing of 128 patients and their 484 potential donors matched for HLA-AB by serology and for HLA-DRB1 by DNA typing. The information on the level of mismatches for certain AB-serotypes is very useful to determine the class I DNA-typing strategy.
18. 18 Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235.
19. 19 Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI: Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB1, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995, 46:355-367.
20. 20 Albis-Camps M, Blasczyk R: Fluorotyping of HLA-DRB by sequence-specific priming and fluorogenic probing. Tissue Antigens 1999, 53:301-307. The authors describe a sequence-specific primer technique for HLA-DR typing in which a positive polymerase chain reaction is detected through a locus-specific fluorescent internal probe cleaved by the 5′-3′ exonuclease activity of the Taq polymerase. This technique, previously reported by the same group for HLA-AI-C could help sequence-specific primer automation substantially.
21. 21 Tiercy J-M, Morel C, Freidel AC, Zwahlen F, Gebuhrer L, Betuel H, et al.: Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc Natl Acad Sci USA 1991, 88:7121-7125.
22. 22 Fernandez-Vina M, Lazaro AM, Sun Y, Miller S, Forero L, Stastny P: Population diversity of B-locus alleles observed by high-resolution DNA typing. Tissue Antigens 1995, 45:153-168.
23. 23 Bugawan TL, Apple R, Erlich HA: A method for typing polymorphism at the HLA-A locus using PCR amplification and immobilized oligonucleotide probes. Tissue Antigens 1994, 44:137-147.
24. 24 Cros P, Allibert P, Mandrand B, Tiercy JM, Mach B: Oligonucleotide genotyping of HLA polymorphism on microtitre plates. Lancet 1992, 340:870-873.
25. 25 Tiercy J-M, Roosnek E, Speiser D, Cros P, Allibert P, Mach B, et al.: Replacement of HLA class II serology by the HLA-DR microtitre plate oligotyping assay: a one-year experience in unrelated bone marrow donor selection. Br J Haematol 1993, 85:417-418.
26. 26 Scheltinga SA, Williams F, van der Zwan AW, Rozemuller EH, Middleton D, Tilanus MG: HLA-A towards a high-resolution DNA typing. Tissue Antigens 1998, 51:549-552.
27. 27 Grundschober C, Labonne MP, Javaux F, Steiner QG, Gebuhrer L, Tiercy JM: Sequence of four new HLA-Cw alleles: a possible role of interallelic recombination. Tissue Antigens 1998, 51:72-79.
28. 28 Lee KW, Steiner N, Hurley CK: Clarification of HLA-B serologically ambiguous types by automated DNA sequencing. Tissue Antigens 1998, 51:536-540.
29. 29 Turner S, Ellexson ME, Hickman HD, Sidebottom DA, Fernandez-Vina M, Confer DL, et al.: Sequence-based typing provides a new look at HLA-C diversity. J Immunol 1998, 161:1406-1413. This is an analysis of HLA-C locus diversity by sequencing the HLA-C alleles of 1823 donors in the NMDP Registry. In total, 48 different sequences were found. The frequency of new sequences, identified in approximately 1% of the individuals, was significantly higher in non-Caucasian patients, which has practical consequences for the routine typing strategy.
30. 30 Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989, 86:2766-2770.
31. 31 Bidwell J: Advances in DNA-based HLA-typing methods. Immunol Today 1994, 15:303-307.
32. 32 Argüello JR, Little AM, Pay AL, Gallardo D, Rojas I, Marsh SG, et al: Mutation detection and typing of polymorphic loci through double-strand conformation analysis. Nat Genet 1998, 18:192-194. These authors describe a method of detecting genetic polymorphisms based on characteristic mobilities of heteroduplex DNA fragments in polyacrylamide gels. The heteroduplexes are formed by reannealing the polymerase chain reaction-amplified fragment of the sequence to be tested with a fluorescein-labeled fragment of one of the alleles of the locus tested. After electrophoresis, the migration of all heteroduplexes formed are measured on an automated DNA sequencer. The authors describe the unique mobilities of 131 HLA class I alleles.
33. 33 Argüello JR, Little AM, Bohan E, Goldman JM, Marsh SG, Madrigal JA: High resolution HLA class I typing by reference strand mediated conformation analysis (RSCA). Tissue Antigens 1998, 52:57-66.
34. 34 Argüello JR, Little AM, Bohan E, Gallardo D, O'Shea J, Dodi IA, et al.: A high resolution HLA class I and class II matching method for bone marrow donor selection. Bone Marrow Transplant 1998, 22:527-534. These authors cover the application of the reference strand-mediated conformation analysis described in references 32 and 33 for compatibility testing of 120 donors selected for 48 patients. The article shows that the method detects sero-logically hidden subtypes and that within 12 hours, multiple donor samples can be processed simultaneously.
35. 35 Mickelson EM, Longton G, Anasetti C, Petersdorf E, Martin P, Guthrie LA, et al.: Evaluation of the mixed lymphocyte culture (MLC) assay as a method for selecting unrelated donors for marrow transplantation. Tissue Antigens 1996, 47:27-36.
36. 36 Rufer N, Tiercy J-M, Speiser D, Helg C, Gratwohl A, Chapuis B, et al.: Characterization of pretransplant CTL activity in "perfectly matched" unrelated bone marrow donor/recipient combinations. Bone Marrow Transplant 1993, 11(Suppl 1):20-23.
37. 37 Shea JO, Madrigal A, Davey N, Brookes P, Scott I, Firman H, et al.: Measurement of cytotoxic T lymphocyte precursor frequencies reveals cryptic HLA class I mismatches in the context of unrelated donor bone marrow transplantation. Transplantation 1997, 64:1353-1356.
38. 38 Rufer N, Starobinski M, Chapuis B, Gratwohl A, Jeannet M, Holg C, et al.: Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation. Bone Marrow Transplant 1998, 22:895-898.
39. 39 Zanone-Ramseier R, Gratwohl A, Roosnek E, Tiercy J-M: Sequencing of two HLA-A blank alleles: implications in unrelated bone marrow donor matching. Transplantation 1999, 67:1336-1341.
40. 40 Hansen JA, Petersdorf E, Martin PJ, Anasetti C: Hematopoietic stem cell transplants from unrelated donors. Irnmunol Rev 1997, 157:141-51.
41. 41 Scott I, O'Shea J, Bunce M, Tiercy JM, Argöello JR, Firman H, et al.: Molecular typing shows a high level of HLA class I incompatibility in sero-logically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. Blood 1998, 92:4864-4871.
42. 42 Grundschober C, Rufer N, Sanchez-Mazas A, Madrigal A, Jeannet M, Roosnek E, et al.: Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Tissue Antigens 1997, 49:612-623.
43. 43 Charron DJ: HLA matching in unrelated donor bone marrow transplantation. Curr Opin Hematol 1996, 3:416-422.
44. 44 Schipper RF, D'Amaro J, Oudshoorn M: The probability of finding a suitable related donor for bone marrow transplantation in extended families. Blood 1996, 87:800-804.
45. 45 Schipper RF, D'Amaro J, Bakker JT, Bakker J, van Rood JJ, Oudshoorn M: HLA gene haplotype frequencies in bone marrow donors worldwide registries. Hum Immunol 1997, 52:54-71.
46. 46 Devergie A, Apperley JF, Labopin M, Madrigal A, Jacobsen N, Carreras E, et al.: European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Bone Marrow Transplant 1997, 20:11-19.